LOS ANGELES, Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. ("Neumora" or "the Company") (NASDAQ: NMRA) for violations of the federal securities laws....
Hence then, the article about nmra investors have opportunity to lead neumora therapeutics inc securities fraud lawsuit with the schall law firm was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm )
Also on site :
- Busan Jury President Zhang Yimou Weighs In on ‘The Assassin(s)’ History Row as Juror July Jung Says Her ‘Heart Feels So Cold’
- Chuck Lorre Says Working on ‘Roseanne’ ‘Was Malice’ Because Roseanne Barr ‘Fundamentally Hated’ the Show’s Writers
- Simon Rodia spent 33 years building 17 towers in his Los Angeles yard from bottles, tiles and seashells; the finished towers are now a national landmark